A review of the therapeutic agents used in the management of polycythaemia vera
β Scribed by Mary Frances McMullin
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 136 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0278-0232
- DOI
- 10.1002/hon.809
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The acquired clonal disorder Polycythaemia Vera leads to increased erythropoiesis, myelopoiesis and megakaryopoeisis. These anomalies result in an increased incidence of thromboembolic events, transformation to acute leukaemia and myelofibrosis. Treatments which aim to reduce the event rate may increase anaemia but may also affect the rate of complications. This paper reviews the evidence for the treatments which have been used in the management of the disorders over a 50 plus year period. Assessment of this evidence and its limitations form the basis for the current suggested management plans. Copyright Β© 2007 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Clonazepam, first used for seizure disorders, is now increasingly used to treat affective disorders. We summarize the use of clonazepam to improve the management of depression. Clonazepam is useful for treatmentβresistant and/or protracted depression, as well as for acceleration of resp
Computer based analysis of evacuation can be performed using one of three di4erent approaches, namely optimization, simulation and risk assessment. Furthermore, within each approach di4erent means of representing the enclosure, the population and the behaviour of the population are possible. The myr